Tender detail

Kardiovaskulaarsüsteemi ja närvisüsteemi ravimid

Summary

The tender concerns the purchase of cardiovascular and nervous system medicines for 24 months. It is a supply contract split into 7 lots, and bids may be submitted for up to all 7 lots. The bidder must take into account that, for some lots, a wholesale pharmaceutical activity licence from the Estonian Medicines Agency is required, and the offered medicines must have either a marketing authorisation or the relevant import/use authorisation. The bid must also include product descriptions and manufacturer information proving compliance, together with the required forms.

Reference number
309102-0000
Buyer
Sihtasutus Ida-Viru Keskhaigla
Country
Estonia (EST)
Procedure
Open procedure
CPV
33660000 Medicinal products for the nervous system and sensory organs
Deadline
2026-04-29
Status
Evaluation
Contract subject
Supplies
Estimated value
53 000 EUR
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

The machine-readable notice includes mandatory exclusion grounds for convictions related to participation in a criminal organisation, corruption, fraud, terrorist offences and related activities, and other standard exclusion grounds listed in the tender passport. If an exclusion ground applies, the bidder may have to provide evidence of self-cleaning where allowed. The exact full list and any detailed conditions must be checked in the tender documents.

Qualification criteria and exclusion grounds

The bidder must hold a wholesale pharmaceutical activity licence issued by the Estonian Medicines Agency for the lots where this requirement applies: lot 1 C03CA04 torasemide, lot 2 N05CM18 dexmedetomidine, lot 3 C01CA07 dobutamine, lot 4 N02BF02 pregabalin, lot 5 N05AH04 quetiapine, lot 6 N06BA04 methylphenidate, and lot 7 N02AA05 oxycodone. The contracting authority checks the licence in the register. The bid must include the participation application on form 1. If the person signing the bid is not authorised in the register, a power of attorney on form 2 must be attached. In the case of a joint bid, an authorised representative must be appointed and a joint bidders' power of attorney must be included. The offered medicines must either have a marketing authorisation from the Medicines Agency or an import/use authorisation issued by the Medicines Agency. Copies of the documents issued by the Medicines Agency must be provided if needed. The bidder must submit the descriptions, manufacturer information and other evidence needed to assess product compliance, so that the contracting authority can verify conformity with the tender documents. The price offer must be submitted on form 4. If an equivalent solution is offered, it must be explained and supporting evidence of equivalence must be attached. The exact detailed requirements must be checked in the tender documents if anything is missing from the machine-readable notice.